S&P 500   3,333.58 (-1.18%)
DOW   28,959.49 (-0.89%)
QQQ   229.72 (-2.16%)
AAPL   310.83 (-2.96%)
FB   209.94 (-2.16%)
MSFT   177.75 (-3.62%)
GOOGL   1,480.71 (-2.39%)
AMZN   2,092.38 (-2.82%)
CGC   21.90 (-1.84%)
NVDA   291.49 (-5.57%)
BABA   211.94 (-2.80%)
MU   56.04 (-5.02%)
GE   12.27 (-2.08%)
TSLA   893.71 (-0.63%)
AMD   53.36 (-6.83%)
T   38.49 (-0.31%)
ACB   1.66 (-1.19%)
F   7.92 (-1.37%)
NFLX   378.68 (-1.90%)
PRI   132.58 (-2.80%)
BAC   34.21 (-1.84%)
DIS   138.64 (-1.23%)
GILD   69.37 (+3.54%)
S&P 500   3,333.58 (-1.18%)
DOW   28,959.49 (-0.89%)
QQQ   229.72 (-2.16%)
AAPL   310.83 (-2.96%)
FB   209.94 (-2.16%)
MSFT   177.75 (-3.62%)
GOOGL   1,480.71 (-2.39%)
AMZN   2,092.38 (-2.82%)
CGC   21.90 (-1.84%)
NVDA   291.49 (-5.57%)
BABA   211.94 (-2.80%)
MU   56.04 (-5.02%)
GE   12.27 (-2.08%)
TSLA   893.71 (-0.63%)
AMD   53.36 (-6.83%)
T   38.49 (-0.31%)
ACB   1.66 (-1.19%)
F   7.92 (-1.37%)
NFLX   378.68 (-1.90%)
PRI   132.58 (-2.80%)
BAC   34.21 (-1.84%)
DIS   138.64 (-1.23%)
GILD   69.37 (+3.54%)
S&P 500   3,333.58 (-1.18%)
DOW   28,959.49 (-0.89%)
QQQ   229.72 (-2.16%)
AAPL   310.83 (-2.96%)
FB   209.94 (-2.16%)
MSFT   177.75 (-3.62%)
GOOGL   1,480.71 (-2.39%)
AMZN   2,092.38 (-2.82%)
CGC   21.90 (-1.84%)
NVDA   291.49 (-5.57%)
BABA   211.94 (-2.80%)
MU   56.04 (-5.02%)
GE   12.27 (-2.08%)
TSLA   893.71 (-0.63%)
AMD   53.36 (-6.83%)
T   38.49 (-0.31%)
ACB   1.66 (-1.19%)
F   7.92 (-1.37%)
NFLX   378.68 (-1.90%)
PRI   132.58 (-2.80%)
BAC   34.21 (-1.84%)
DIS   138.64 (-1.23%)
GILD   69.37 (+3.54%)
S&P 500   3,333.58 (-1.18%)
DOW   28,959.49 (-0.89%)
QQQ   229.72 (-2.16%)
AAPL   310.83 (-2.96%)
FB   209.94 (-2.16%)
MSFT   177.75 (-3.62%)
GOOGL   1,480.71 (-2.39%)
AMZN   2,092.38 (-2.82%)
CGC   21.90 (-1.84%)
NVDA   291.49 (-5.57%)
BABA   211.94 (-2.80%)
MU   56.04 (-5.02%)
GE   12.27 (-2.08%)
TSLA   893.71 (-0.63%)
AMD   53.36 (-6.83%)
T   38.49 (-0.31%)
ACB   1.66 (-1.19%)
F   7.92 (-1.37%)
NFLX   378.68 (-1.90%)
PRI   132.58 (-2.80%)
BAC   34.21 (-1.84%)
DIS   138.64 (-1.23%)
GILD   69.37 (+3.54%)
Log in

NYSE:PFE - Pfizer Stock Price, Forecast & News

$35.70
-0.15 (-0.42 %)
(As of 02/21/2020 02:31 PM ET)
Today's Range
$35.53
Now: $35.71
$35.82
50-Day Range
$36.23
MA: $38.65
$40.71
52-Week Range
$33.97
Now: $35.71
$44.56
Volume18.02 million shs
Average Volume24.96 million shs
Market Capitalization$197.60 billion
P/E Ratio12.44
Dividend Yield4.20%
Beta0.67
Pfizer Inc discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP71708110
Phone212-733-2323

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$51.75 billion
Cash Flow$3.80 per share
Book Value$11.03 per share

Profitability

Net Income$16.27 billion

Miscellaneous

Employees92,400
Outstanding Shares5,534,120,000
Market Cap$197.60 billion
Next Earnings Date5/5/2020 (Estimated)
OptionableOptionable

Receive PFE News and Ratings via Email

Sign-up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter.


Pfizer (NYSE:PFE) Frequently Asked Questions

What is Pfizer's stock symbol?

Pfizer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PFE."

How often does Pfizer pay dividends? What is the dividend yield for Pfizer?

Pfizer declared a quarterly dividend on Monday, December 16th. Investors of record on Friday, January 31st will be given a dividend of $0.38 per share on Friday, March 6th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 4.26%. The ex-dividend date is Thursday, January 30th. This is an increase from Pfizer's previous quarterly dividend of $0.36. View Pfizer's Dividend History.

How will Pfizer's stock buyback program work?

Pfizer announced that its board has authorized a share buyback plan on Friday, December 14th 2018, which permits the company to buyback $10,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase up to 3.8% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's management believes its stock is undervalued.

How were Pfizer's earnings last quarter?

Pfizer Inc. (NYSE:PFE) announced its quarterly earnings data on Tuesday, January, 28th. The biopharmaceutical company reported $0.55 EPS for the quarter, missing the Zacks' consensus estimate of $0.57 by $0.02. The biopharmaceutical company earned $12.69 billion during the quarter, compared to the consensus estimate of $12.73 billion. Pfizer had a return on equity of 27.23% and a net margin of 31.44%. The firm's revenue for the quarter was down 9.2% on a year-over-year basis. During the same period last year, the company earned $0.64 EPS. View Pfizer's Earnings History.

When is Pfizer's next earnings date?

Pfizer is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Pfizer.

What guidance has Pfizer issued on next quarter's earnings?

Pfizer issued an update on its FY20 earnings guidance on Tuesday, January, 28th. The company provided EPS guidance of $2.82-$2.92 for the period, compared to the Thomson Reuters consensus estimate of $2.72. The company issued revenue guidance of $48.5-$50.5 billion, compared to the consensus revenue estimate of $47.44 billion.

What price target have analysts set for PFE?

11 analysts have issued 1-year target prices for Pfizer's shares. Their forecasts range from $36.00 to $53.00. On average, they expect Pfizer's share price to reach $42.12 in the next twelve months. This suggests a possible upside of 18.1% from the stock's current price. View Analyst Price Targets for Pfizer.

What is the consensus analysts' recommendation for Pfizer?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last year. There are currently 7 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Pfizer.

Has Pfizer been receiving favorable news coverage?

Press coverage about PFE stock has trended extremely negative this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Pfizer earned a coverage optimism score of -4.2 on InfoTrie's scale. They also assigned media stories about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Pfizer.

Who are some of Pfizer's key competitors?

What other stocks do shareholders of Pfizer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pfizer investors own include AT&T (T), Cisco Systems (CSCO), Verizon Communications (VZ), Johnson & Johnson (JNJ), Intel (INTC), General Electric (GE), AbbVie (ABBV), Bank of America (BAC), Exxon Mobil (XOM) and Walt Disney (DIS).

Who are Pfizer's key executives?

Pfizer's management team includes the folowing people:
  • Mr. Ian C. Read, Exec. Chairman (Age 65)
  • Mr. Albert Bourla D.V.M., DVM, Ph.D., CEO & Director (Age 57)
  • Mr. Frank A. D'Amelio, CFO & EVP of Global Supply & Bus. Operations (Age 61)
  • Dr. Mikael Dolsten, Chief Scientific Officer & Pres of Worldwide Research, Devel. and Medical (Age 60)
  • Mr. John D. Young, Group Pres & Chief Bus. Officer (Age 54)

Who are Pfizer's major shareholders?

Pfizer's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include State Street Corp (5.27%), Capital World Investors (3.41%), Geode Capital Management LLC (1.61%), Bank of New York Mellon Corp (1.08%), Massachusetts Financial Services Co. MA (0.94%) and Charles Schwab Investment Management Inc. (0.72%). Company insiders that own Pfizer stock include Alexander R Mackenzie, Charles H Hill, Dawn Rogers, Douglas M Lankler, Frank A Damelio, Ian C Read, Kirsten Lund-Jurgensen, Laurie J Olson, Loretta V Cangialosi, Mikael Dolsten, Pfizer Inc, Rady A Johnson, Sally Susman, Scott Gottlieb and W Don Cornwell. View Institutional Ownership Trends for Pfizer.

Which institutional investors are selling Pfizer stock?

PFE stock was sold by a variety of institutional investors in the last quarter, including Capital International Investors, Massachusetts Financial Services Co. MA, PGGM Investments, California Public Employees Retirement System, LSV Asset Management, CI Investments Inc., PNC Financial Services Group Inc. and KBC Group NV. Company insiders that have sold Pfizer company stock in the last year include Alexander R Mackenzie, Dawn Rogers, Frank A Damelio, Mikael Dolsten and Rady A Johnson. View Insider Buying and Selling for Pfizer.

Which institutional investors are buying Pfizer stock?

PFE stock was bought by a variety of institutional investors in the last quarter, including Capital World Investors, Renaissance Technologies LLC, Marshall Wace North America L.P., Sanders Capital LLC, Bank of New York Mellon Corp, FIL Ltd, Sound Shore Management Inc. CT and Marshall Wace LLP. Company insiders that have bought Pfizer stock in the last two years include Pfizer Inc and Scott Gottlieb. View Insider Buying and Selling for Pfizer.

How do I buy shares of Pfizer?

Shares of PFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Pfizer's stock price today?

One share of PFE stock can currently be purchased for approximately $35.67.

How big of a company is Pfizer?

Pfizer has a market capitalization of $197.40 billion and generates $51.75 billion in revenue each year. The biopharmaceutical company earns $16.27 billion in net income (profit) each year or $2.95 on an earnings per share basis. Pfizer employs 92,400 workers across the globe.View Additional Information About Pfizer.

What is Pfizer's official website?

The official website for Pfizer is http://www.pfizer.com/.

How can I contact Pfizer?

Pfizer's mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company can be reached via phone at 212-733-2323.


MarketBeat Community Rating for Pfizer (NYSE PFE)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  1,343 (Vote Outperform)
Underperform Votes:  962 (Vote Underperform)
Total Votes:  2,305
MarketBeat's community ratings are surveys of what our community members think about Pfizer and other stocks. Vote "Outperform" if you believe PFE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PFE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Featured Article: Pattern Day Trader

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel